NCT06780514 Cardiopulmonary Exercise Testing in Girls (8-18y) with Turner Sydrome.
| NCT ID | NCT06780514 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Ghent |
| Condition | Turner Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-01-31 |
| Primary Completion | 2026-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-01-31 with a primary completion date of 2026-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to have a beter insight in the exercise tolerance in girls with Turner Syndrome aged 8-18 years . The main question it aims to answer is: Is there a difference in VO2 max comparing Turner syndrome girls with standard values? How do cardiovascular parameters change during exercise (heart rate, bloodpressure, ...) Participants will perform a cyclo-ergometry in a standardised way.
Eligibility Criteria
Inclusion Criteria: * Turner syndrome girls aged 8-18 years old Exclusion Criteria: * Severe mental impairement making it impossible to perform an exercise test
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06780514 clinical trial?
This trial is open to female participants only, aged 8 Years or older, up to 18 Years, studying Turner Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06780514 currently recruiting?
Yes, NCT06780514 is actively recruiting participants. Contact the research team at bauke.debo@uzgent.be for enrollment information.
Where is the NCT06780514 trial being conducted?
This trial is being conducted at Ghent, Belgium.
Who is sponsoring the NCT06780514 clinical trial?
NCT06780514 is sponsored by University Hospital, Ghent. The trial plans to enroll 20 participants.